J Biol Chem, Vol. 274, Issue 38, 27274-27280, September 17, 1999
Clostridium septicum Alpha Toxin Uses
Glycosylphosphatidylinositol-anchored Protein Receptors*
Valery M.
Gordon
,
Kim L.
Nelson§,
J. Thomas
Buckley§,
Victoria L.
Stevens¶,
Rodney K.
Tweten
,
Patrick C.
Elwood**, and
Stephen H.
Leppla

From the
Oral Infection and Immunity Branch, NIDCR,
National Institutes of Health, Bethesda, Maryland 20892, the
§ Department of Biochemistry and Microbiology, University of
Victoria, British Columbia V8W 3P6, Canada, the ¶ Division
of Cancer Biology, Department of Radiation Oncology, Emory University
School of Medicine, Atlanta, Georgia 30335, the
Department of
Microbiology and Immunology, BMSB-1011, University of Oklahoma
Health Sciences Center, Oklahoma City, Oklahoma 73190, and the
** Medicine Branch, Division of Clinical Sciences, NCI, National
Institutes of Health, Bethesda, Maryland 20892
 |
ABSTRACT |
The alpha toxin produced by Clostridium
septicum is a channel-forming protein that is an important
contributor to the virulence of the organism. Chinese hamster ovary
(CHO) cells are sensitive to low concentrations of the toxin,
indicating that they contain toxin receptors. Using retroviral
mutagenesis, a mutant CHO line (BAG15) was generated that is resistant
to alpha toxin. FACS analysis showed that the mutant cells have lost
the ability to bind the toxin, indicating that they lack an alpha toxin
receptor. The mutant cells are also resistant to aerolysin, a
channel-forming protein secreted by Aeromonas spp., which
is structurally and functionally related to alpha toxin and which is
known to bind to glycosylphosphatidylinositol (GPI)-anchored proteins,
such as Thy-1. We obtained evidence that the BAG15 cells lack
N-acetylglucosaminyl-phosphatidylinositol deacetylase-L,
needed for the second step in GPI anchor biosynthesis. Several
lymphocyte cell lines lacking GPI-anchored proteins were also shown to
be less sensitive to alpha toxin. On the other hand, the sensitivity of
CHO cells to alpha toxin was increased when the cells were transfected
with the GPI-anchored folate receptor. We conclude that alpha toxin,
like aerolysin, binds to GPI-anchored protein receptors. Evidence is
also presented that the two toxins bind to different subsets of
GPI-anchored proteins.
 |
INTRODUCTION |
Infection with Clostridium septicum is associated with
a frequently fatal, nontraumatic gas gangrene (1). Distal myonecrosis due to C. septicum occurs mainly in individuals with certain
predisposing conditions such as colon cancer, leukemia, neutropenia,
and diabetes (2). Although this pathogen secretes a number of toxic
proteins, including deoxyribonuclease and hyaluronidase, the lethal,
cytolytic alpha toxin is implicated as the major virulence factor and
appears to be the immunodominant extracellular antigen (3).
The C. septicum alpha toxin is a member of a group of
pore-forming protein toxins, of which Aeromonas hydrophila
aerolysin is perhaps the best characterized member (4). In addition to their ability to form channels in target cell membranes, aerolysin and
alpha toxin share several other properties, despite the fact that they
are produced by bacteria widely separated in evolution. Both proteins
are secreted from the bacteria as protoxins, and both are activated by
proteolytic nicking near their C termini (5, 6). A number of proteases
are capable of accomplishing activation, perhaps most notably the
eukaryotic protease furin (7). Activation results in the formation of
extremely stable oligomers that are believed to be the
insertion-competent forms of the toxins (8). The crystal structure of
proaerolysin has been solved (9). The protein consists of two lobes, a
small lobe containing the first 80 amino acids of the protein and a larger lobe containing the rest of the protein. A number of studies have shown that the large lobe is involved in oligomerization of the
toxin, as well as in activation (10, 11). Remarkably, alpha toxin
shares extensive sequence homology with the large lobe of aerolysin,
accounting for some of the functional similarities between the toxins.
Indeed, one of us has speculated that the two toxins have a common
ancestor and that aerolysin obtained its smaller lobe by domain
swapping (12). Recently a common fold has been observed in the small
lobe of aerolysin and the S2 and S3 subunits of pertussis toxin (12).
This fold is similar to the carbohydrate recognition domains of a
number of proteins, implying it has a binding function in both toxins.
In the last several years, Howard and Buckley (13) showed that
receptors that can bind aerolysin with high affinity can account for
the sensitivity of some mammalian cells to the toxin, and also in the
last several years, a number of aerolysin receptors have been
identified on sensitive cells. These proteins appear to be unrelated
except for one remarkable property: they are all attached to the cell
surface by means of C-terminal glycosylphosphatidylinositol (GPI)1 anchors. Examples are
Thy-1 (CD90), which is found in T-lymphocytes and brain (14), the
neuronal surface molecule contactin (15), the 47-kDa erythrocyte
aerolysin receptor (12, 16), and the variant surface glycoprotein of
Trypanosoma brucei (15). Recent evidence indicates that the
glycosyl portion of the receptor is the major binding determinant for
aerolysin. Cell lines that lack the ability to make GPI anchors are
much less sensitive to aerolysin (14), as are cells that have been
treated with phosphatidyl-inositol-specific phospholipase C
(PI-PLC) (15), which can remove most GPI-anchored proteins (17).
Gordon et al. (7) explored the cellular requirements for
alpha toxin sensitivity. One requirement is the presence of functional proteases to accomplish the conversion of the proform of the protein to
the active toxin. Cells that lack furin, a surface protease that can
correctly nick the protoxin, are lysed more slowly than those that
express the protease (7). Another requirement for sensitivity is the
ability of cells to localize alpha toxin on the cell surface,
presumably through specific receptors. Until this time, no receptors
have been identified for alpha toxin. Characterization of the receptors
for other toxins has been aided by somatic cell mutagenesis methods
(18, 19). In this communication, we describe isolation and
characterization of an alpha toxin-resistant CHO cell that is unable to
bind the toxin. We show that the mutant cells lack the ability to
synthesize GPI anchors and provide other evidence that GPI-anchored
proteins are receptors for alpha toxin.
 |
EXPERIMENTAL PROCEDURES |
Materials--
C. septicum alpha toxin was produced
in Escherichia coli as described previously (20). For
biotinylation, 6 mg of alpha toxin in phosphate-buffered saline, pH
9.0, was reacted with 1 mg of sulfosuccinimidyl-6-(biotinamido)
hexanoate (Pierce, catalog no. 21335) for 2 h on ice. Toxicity
tests showed that the biotinylated toxin was fully active. Aerolysin
was purified from A. hydrophila as described previously
(21). PI-PLC was purchased from Roche Molecular Biochemicals.
Cell Lines--
Murine T lymphocyte cell lines AKR1 and EL4 and
their derivatives, AKR1 (Thy-1
d) and EL4
(Thy-1
f), were generously provided by Dr. R. Hyman (Salk
Institute). The murine T lymphocyte cell lines BW5147.3 and
BW5147.3(Thy-1
e).10 were purchased from the ATCC.
Lymphocyte cell lines were grown in Dulbecco's modified Eagle's
medium containing 4.5 g of glucose per liter, 10% (v/v) fetal
bovine serum, and antibiotics (either 100 µg/ml streptomycin and 100 units/ml penicillin, or 50 µg/ml gentamicin). The CHO cell line
transfected with the human folate receptor, referred to here as CHO
FR+, is the previously described CHO clone 2-8 (22). CHO cells were
grown in
-minimal essential medium (Biofluids, Inc.) supplemented
with 10% Fetal Clone II (HyClone, Logan, UT) and 50 µg/ml gentamicin.
CHO lec2 cells (23) were purchased from the ATCC. CHO lec2 cells were
selected sequentially with 5 µM thioguanine and then 2 mM ouabain to obtain spontaneous mutants sensitive to
hypoxanthine/aminopterin/thymidine medium and resistant to ouabain.
These marked lines are considered "universal hybridizers," because
they can be fused to unmarked cells for complementation analyses. In
such fusions, both parents are killed by the combination of ouabain and
hypoxanthine/aminopterin/thymidine medium, whereas fusion products
survive. The resulting cloned cell line, CHO lec2 UH, was used as the
parent for mutagenesis. It did not differ from CHO lec2 in toxin
sensitivity, so these two lines were used interchangeably as controls
in cytotoxicity comparisons with the mutant CHO cell line described below.
Retroviral Mutagenesis of CHO lec2 UH Cells--
CHO lec2 UH
cells were treated in the presence of 4 µg/ml Polybrene with four
additions of a stock of a Moloney murine leukemia virus-based
retroviral vector designated BAG (24). This vector expresses
-galactosidase from the viral LTR promoter and the neo
gene from an SV40 promoter. Three days later, the cells were exposed to
10 ng/ml alpha toxin for 24 h. Dead cells and medium were removed,
fresh medium was added, and the dishes were left undisturbed for 7 days. Colonies of surviving cells were expanded in 24-well dishes and
tested for sensitivity to several toxins, resistance to G418, and for
expression of
-galactosidase. Clones that were confirmed as
resistant to alpha toxin and that expressed
-galactosidase were
recloned by limiting dilution. One of these was designated CHO lec2 UH BAG15.
Cytotoxicity Assays with Adherent Cells (CHO)--
One day prior
to the assay, cells were detached from flasks using trypsin-EDTA (Life
Technologies, Inc.) and plated at 2 × 105 cells/ml in
96-well microtiter plates. The following day, toxin diluted in culture
medium was added to the wells, and the plates were incubated for 1 h at 37 °C. Cell viability was assessed by the addition of 0.5 mg/ml
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as
described previously (7). In assays in which CHO lec2 cells were
treated with PI-PLC, adherent monolayers were incubated with 1 unit/ml
PI-PLC for 60 min and then washed just prior to the addition of alpha toxin.
Cytotoxicity Assays with Nonadherent Cells (EL4, AKR1, and
BW5147.3)--
Cells were aliquoted at 2 × 105
cells/ml into 96-well microtiter plates and incubated with toxin
dilutions for 1 h at 37 °C. Viability was measured by using
either MTT or the combination of 3-(4,
5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (Promega) with phenazine methosulphonate (Sigma). In the former case,
MTT was added at a final concentration of 1 mg/ml, and the plates were
incubated for an additional 2 h. An equal volume of lysing
solution (20% (w/v) SDS, 50% (v/v) dimethyl formamide, pH 4.7) was
added, and the plates were incubated 2-16 h. Viability was
assessed by measuring A540 and
A650 and performing the following calculation:
percentage of viability = 100 × (toxin-treated
(A540
A650)
background (A540
A650))/(non-toxin-treated
(A540
A650)
background (A540
A650)). In the latter method (25), the
tetrazolium salt 3-(4,
5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and the electron acceptor phenazine methosulphate were added to final
concentrations of 333 µg/ml and 25 µM, respectively.
The plates were incubated at 37 °C and 5% CO2 for
4 h, after which A490 was measured. In
assays for susceptibility of the toxin receptor to treatment with
PI-PLC, 5 ml of 2.5 × 106 cells/ml were treated with
500 milliunits of PI-PLC per ml for 2 h at 37 °C. Cells were
then pelleted by brief centrifugation, the supernatant was removed, and
cells were resuspended in 5 ml of Dulbecco's modified Eagle's medium
containing 10% fetal bovine serum. Cells (100 µl) were then
incubated with specified toxin concentrations for 1 h at 37 °C
as described above.
FACS Measurement of C. septicum Alpha Toxin Binding to
Cells--
CHO lec2 and CHO lec2 UH BAG15 cells were aliquoted into
24-well plates at 1 × 105 cells/ml. Following an
overnight incubation at 37 °C in 5% CO2, the plates
were cooled to 4 °C. The medium was aspirated and 1 µg/ml
biotinylated alpha toxin or 20 µg/ml native alpha toxin was added in
precooled binding medium (minimum essential medium with Hanks' salts)
(Life Technologies, Inc., catalog no. 11570), containing a low
NaHCO3 concentration (4.5 mM), supplemented
with 2 mM L-glutamine, 4 mM HEPES,
pH 8.0, and 1% (w/v) bovine serum albumin). After a 1.5-h incubation
at 4 °C, the plate was washed 5 times with chilled binding medium.
Phycoerythrin-labeled streptavidin (1:1000, Molecular Probes, Inc) or
binding medium (200 µl) was added, and the cells were incubated for
30 min at 4 °C, followed by extensive washing with binding medium.
The cells were detached from the surface of the plates using 500 µl
of a nonproteolytic, EDTA-based solution (Cell Dissociation Solution,
Life Technologies, Inc., catalog no. 13150-016), and analyzed for
relative fluorescence using FACscan (Becton Dickinson, Mountain View, CA).
In Vitro Biosynthesis of GPI Intermediates--
The microsomal
fraction was isolated from cells disrupted by nitrogen cavitation using
differential centrifugation as described previously (26). The final
microsomal pellets were resuspended and frozen in a solution of 10 mM HEPES, pH 7.5, 0.5 mM dithiothreitol, 0.1 mM tosyl-L-lysine chloromethylketone, 1 µg/ml
leupeptin, and 10% glycerol. Protein was quantitated using the
bicinchoninic acid assay (27). Biosynthesis of GPI intermediates from
UDP-[6-3H]GlcNAc (1 µCi) by microsomes (approximately
60 µg of protein) was measured in a reaction mixture of 50 mM HEPES, pH 7.5, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.1 mM
tosyl-L-lysine chloromethylketone, 1 µg/ml leupeptin, 0.2 µg/ml tunicamycin, 1 mM ATP, and 1 mM EDTA (total volume of 300 µl). Deacetylation of
[3H]GlcNAc-PI (10,000 cpm), enzymatically prepared as
described previously (26), was measured using the same conditions
except that ATP and EDTA were omitted from the reaction mixture. GTP (1 mM) and CoA (1 µM) were included as
indicated. After incubation for the indicated time at 37 °C, the
reaction was stopped by the addition of 0.5 ml of H2O and 3 ml of chloroform/methanol (2:1 (v/v)) containing 0.1 N HCl.
The radiolabeled GPI precursors were then extracted using the method of
Bligh and Dyer (28) and analyzed by TLC as described previously
(29).
Western Blotting Procedures--
Rat brain homogenate (1.0 ml)
was treated with 400 milliunits of PI-PLC and centrifuged as described
previously (14). Rat erythrocyte membranes were prepared as described
previously (30). Samples were separated by SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose using standard
procedures. Two methods were used to detect materials that bind toxin.
In the first method, used for Figs. 6, 10, and 11, blots were blocked
with 5% skim milk in phosphate-buffered saline containing 0.5% Tween 20. All subsequent incubations were in phosphate-buffered saline with
0.5% Tween 20. The blots were incubated with either aerolysin or alpha
toxin, followed by polyclonal anti-aerolysin or anti-alpha toxin and
anti-rabbit horseradish peroxidase (HRP) conjugate. Blots were then
developed by enhanced chemiluminescence (Amersham Pharmacia Biotech).
In the second method, used for Fig. 9, blots were blocked with
phosphate-buffered saline containing 5% (w/v) dried skim milk, and all
subsequent buffers contained 0.05% Tween 20. The blots were incubated
with 1 µg/ml biotinylated alpha toxin, washed, and incubated with a
horseradish peroxidase conjugate of streptavidin (Kirkegaard & Perry
Laboratories, Inc.). The bound peroxidase was visualized with a
tetramethylbenzidine reagent.
 |
RESULTS |
Isolation of an Alpha Toxin-Resistant Cell Line by Retroviral
Mutagenesis--
We used retroviral insertional mutagenesis to
identify genes required for the lysis of CHO cells by C. septicum alpha toxin. Recent work showed that CHO cells contain a
cryptic receptor for Moloney murine leukemia virus (31). This receptor
becomes functional when glycosylation is blocked, as can be achieved by
treatment with tunicamycin or by mutation. Mutant CHO cell lines
defective in various steps in glycosylation are available (23, 32). The
CHO lec2 mutant cell line proved to be highly susceptible to the
Moloney murine leukemia viral vector BAG (24) produced in the PA317
packaging cell line (ATCC CRL-9078). We selected spontaneous mutants of
CHO lec2 having resistance to thioguanine and to ouabain so that any
toxin-resistant mutants obtained could be analyzed by complementation
analysis. The resulting universal hybridizer cell line was designated
CHO lec2 UH. The introduction of the thioguanine and ouabain
resistances did not affect sensitivity to any of the toxins used in
this work.
Approximately 108 CHO lec2 UH cells were treated with the
BAG retroviral vector. After allowing cell growth for expression of
mutations, the cells were selected with 10 ng/ml alpha toxin, a dose
previously found to kill >99% of the cells. Rare surviving cells were
cloned and then compared with the parental line for sensitivity to
several toxins. Resistant colonies were obtained at a frequency of
approximately 10
7. One group of mutants displayed an
intermediate level of resistance, with an EC50 (effective
concentration causing 50% death) of about 200 ng/ml, as compared with
an EC50 of 5 ng/ml for the CHO lec2 and CHO lec2 UH
parents. This group has not been studied further. Another group of
mutants, obtained at about the same frequency, was completely resistant
to the toxin. A mutant characteristic of this group, designated CHO
lec2 UH BAG15, was unaffected by alpha toxin at concentrations of 1 µg/ml (2.2 × 10
8 M), the highest
concentration tested (Fig. 1,
closed symbols). Comparable mutants, ones having
intermediate and complete resistance to alpha toxin, were also obtained
after chemical mutagenesis with ethylmethane sulfonate (data not
shown). These chemically induced mutant cell lines have not been
further characterized. Because it is expected that most loss of
function mutations would be recessive, these results suggest that the
loci being mutated by both the retroviral and chemical methods were
already functionally hemizygous (i.e. haploid). CHO cells
are unique in that they appear to be functionally hemizygous at many
loci (33).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Sensitivity of CHO lec2 and CHO lec2 UH BAG15
cells to alpha toxin and aerolysin. CHO lec2 and CHO lec2 UH BAG15
cells were incubated with alpha toxin or aerolysin as described in the
text for 1 h at 37 °C. MTT at 0.5 mg/ml was added, and the
cells were incubated at 37 °C for an additional 1 h. The blue
formazan crystals were dissolved, and cell viability was determined by
measuring A450 A650.
The data shown are for a single experiment that is representative of
three or more assays
|
|
CHO lec2 UH BAG15 Cells Cannot Bind C. septicum Alpha
Toxin--
CHO lec2 UH BAG15 cells could be resistant to alpha toxin
because they lack a surface receptor and are unable to bind the toxin.
To investigate this possibility, the binding of alpha toxin to the
parent and mutant cell lines was measured by FACScan analysis using
biotinylated alpha toxin and a phycoerythrin-streptavidin conjugate.
The parental cells were highly fluorescent, with a mean relative
fluorescence intensity at least 10-fold above that of the mutant cells
(Fig. 2A) and of controls
using nonbiotinylated toxin (Fig. 2B). The low fluorescence
of the mutant cells and of the controls is the intrinsic fluorescence
of the cells, because it equaled that of cells not incubated with the
phycoerythrin reagent (data not shown). The data show that the mutant
cells have no detectable ability to bind alpha toxin.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Mutant CHO lec2 UH BAG15 cells have lost the
ability to bind alpha toxin. Cells grown to near confluence in
24-well plates were maintained at 4 °C and incubated with 1 µg/ml
biotinylated alpha toxin (A) or 20 µg/ml native alpha
toxin (B) for 1.5 h. The cells were washed, incubated
with phycoerythrin-conjugated streptavidin for 0.5 h, washed
again, and detached from the plates, and the fluorescence was analyzed
by FACS. The solid line is the result with CHO lec2 cells,
and the dotted line is the result with CHO lec2 UH BAG15
cells.
|
|
CHO lec2 UH BAG15 Cells Are Also Insensitive to A. hydrophila
Aerolysin--
As stated earlier, alpha toxin is structurally and
functionally related to the Aeromonas channel-forming
protein aerolysin, and it is likely the two toxins arose from a common
ancestor (12, 20). It therefore seemed probable that the toxins may
have similar receptors. Resistance of the CHO lec2 UH BAG15 cells to
aerolysin would imply that the two toxins bind to the same receptor.
The CHO lec2 and CHO lec2 UH BAG15 cells were tested for sensitivity to
aerolysin and alpha toxin in MTT assays (Fig. 1). The parental line,
CHO lec2, was sensitive to both toxins, whereas CHO lec2 UH BAG15 was
completely resistant to aerolysin at the concentration tested, as it
was to alpha toxin.
CHO lec2 UH BAG15 Cells Are Deficient in the Second Step of GPI
Anchor Biosynthesis--
Based on the above results, it seemed likely
that the mutant CHO cell line we produced would be deficient in
synthesis of GPI-anchored proteins. The first three steps in GPI anchor
biosynthesis are as follows.
Using different assay conditions to optimize each of these
reactions (addition of GTP to stimulate the second reaction and GTP + CoA to stimulate the third reaction), we showed that CHO lec2 UH BAG15
cells are deficient in the second enzyme in GPI anchor biosynthesis,
N-acetylglucosaminyl-phosphatidylinositol deacetylase
(PIG-L). Microsomes prepared from parental and mutant cells were
assayed for the ability to convert 3H-UDP-GlcNAc to the
products of the three steps shown above (Fig. 3, lanes 1-6). All three
products were synthesized normally by the parental cells (Fig. 3,
lanes 1-3). The BAG15 microsomes synthesized GlcNAc-PI, the
product of the first reaction, but neither of the later two products
(Fig. 3, lanes 4-6), indicating that they were deficient in
the second and possibly the third steps in GPI biosynthesis. To measure
the second step in isolation, microsomes were incubated with
3H-GlcNAc-PI. The parental cells, but not the mutant cells,
were able to deacetylate this substrate to produce GlcN-PI (Fig. 3, lanes 7-10). These results show that the BAG15 mutant cells
lack PIG-L. This enzyme has been shown to be missing in other CHO
mutants defective in GPI biosynthesis (34, 35).

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 3.
Biosynthesis of GPI intermediates by
microsomes prepared from wild type and mutant CHO cells.
Microsomes from CHO lec2 cells (lanes 1, 2, 3, 7, and
8) or CHO lec2 UH BAG15 cells (lanes 4-6, 9, and
10) were incubated with UDP-[6-3H]GlcNAc
(lanes 1-6) or [3H]GlcNAc-PI (lanes
7-10) in the presence of no effectors (lanes 1, 4, 7, and 9), 1 mM GTP (lanes 2, 5, 8, and
10) or GTP + 1 µM CoA (lanes 3 and
6). GPI precursors were then extracted and analyzed by TLC.
The arrows on the left indicate the mobility of
standards for GlcN-PI(acyl), GlcNAc-PI, and GlcN-PI.
|
|
CHO Cells Treated with PI-PLC Are Less Sensitive to Alpha
Toxin--
One feature of the GPI-anchored proteins shown to be
aerolysin receptors is that they can be removed from the cell surface by treatment with PI-PLC, and it has been established that cell sensitivity to aerolysin is greatly reduced by this treatment (15).
Treatment of CHO lec2 cells with PI-PLC reduced their sensitivity to
alpha toxin by about 10-fold (Fig. 4),
providing more evidence that the clostridial toxin binds to a surface
GPI-anchored protein.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
PI-PLC treatment of CHO cells reduces their
sensitivity to alpha toxin. CHO cells were incubated for 60 min
with 1 unit/ml PI-PLC, washed with cell culture medium, and immediately
treated with alpha toxin for 1 h at 37 °C. MTT at a final
concentration of 0.5 mg/ml was added, and the cells were incubated at
37 °C for 1 h. The blue formazan crystals were dissolved, and
cell viability was determined by measuring A540 A650.
|
|
Cells Lines Lacking GPI-anchored Proteins Are Less Sensitive to
Alpha Toxin--
A number of cell lines are known to lack specific
enzymes required for the synthesis of GPI anchors and as a result
cannot retain proteins that are normally anchored in this way on their surfaces (36, 37). Several of these cell lines, including the mouse
lymphocyte mutant cell line EL4 (Thy-1
f), have been shown
to be resistant to aerolysin, and this has been used as more evidence
that aerolysin binds to GPI-anchored proteins (14). The results in Fig.
5 illustrate that these cells are also
resistant to alpha toxin, whereas the parental EL4 cell line is
sensitive.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
GPI anchor-deficient EL4
(Thy-1 f) cells are resistant to
alpha toxin and aerolysin. EL4 and EL4 (Thy-1 f)
cells were incubated with alpha toxin for 1 h at 37 °C. MTT at
0.5 mg/ml was added, and the cells were incubated at 37 °C for an
additional 1 h. The blue formazan crystals were dissolved, and
cell viability was determined by measuring A540 A650. The data shown are for a single
experiment that is representative of three or more assays
|
|
Alpha Toxin Binds Specifically to GPI-anchored Proteins--
Using
a sandwich Western blotting procedure, we previously identified several
proteins in brain and erythrocytes that bind aerolysin (14-16, 30).
These toxin-binding proteins are easily observed in Fig.
6A. Supernatants from
PI-PLC-treated brain extracts contain two major GPI-anchored proteins,
contactin, which migrates at ~110 kDa, and Thy-1, at ~35 kDa (Fig.
6A, lane 1). Three faint bands migrating between contactin
and Thy-1 are also observed. A single aerolysin-binding protein of 47 kDa, which we have also shown is GPI-anchored (30), can be identified
in erythrocytes (Fig. 6A, lane 2). We screened the same
samples of brain and erythrocytes with alpha toxin, using the same
Western blotting procedure. The results in Fig. 6B show that
alpha toxin binds to a band corresponding to contactin in brain as well
as to the three minor GPI-anchored proteins that bound aerolysin.
Surprisingly, the blotting procedure with alpha toxin did not detect
Thy-1, despite the fact that it was the strongest band detected with
aerolysin and that it is probably the major GPI-anchored protein in
brain. The alpha toxin blotting procedure also did not detect the
47-kDa aerolysin-binding protein of erythrocytes.

View larger version (90K):
[in this window]
[in a new window]
|
Fig. 6.
Aerolysin and alpha toxin bind to
GPI-anchored proteins. Rat brain homogenate was treated with 400 milliunits PI-PLC and centrifuged. The resulting supernatant
(lane 1) and rat erythrocyte membranes (lane 2)
were separated by SDS-polyacrylamide gel electrophoresis and blotted.
Blots were developed with 2 × 10 8 M
aerolysin (A) or alpha toxin (B), followed by
polyclonal antisera and a HRP-anti-rabbit conjugate. Blots were then
developed with a chemiluminescence reagent (ECL, Amersham Pharmacia
Biotech). Double arrows (from top to
bottom) mark the positions of 109-, 46-, 34-, and 27-kDa
standards.
|
|
GPI-anchored Proteins Other Than Thy-1 Can Serve as Alpha Toxin
Receptors in Mouse T-Lymphocytes--
Because alpha toxin does not
appear to bind to Thy-1, we asked whether cells lacking only this one
GPI-anchored protein would be sensitive to the toxin. The mutant
T-lymphocyte cell line AKR1 (Thy-1
d) is unable to make
Thy-1 due to mutation of the structural gene, but it retains the
ability to make other GPI-anchored proteins. The results in Fig.
7 show that this cell line is as
sensitive to alpha toxin as the parental cell line, AKR1
(Thy-1+). However, the cells became about 10-fold less
sensitive to alpha toxin after treatment with PI-PLC. These data
indicate that there is at least one GPI-anchored protein other than
Thy-1 in T-lymphocytes that can act as a receptor for alpha toxin. We
have drawn a similar conclusion with aerolysin.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 7.
Thymocytes lacking Thy-1 have other
GPI-anchored alpha toxin receptors. Parental AKR1
(Thy-1+) cells and mutant, Thy-1-deficient AKR1
(Thy-1 d) cells with and without PI-PLC treatment were
incubated with alpha toxin as described under "Experimental
Procedures," and viability was measured. Bars represent the S.E. of
three separate samples. The data shown are for a single experiment that
is representative of three or more assays.
|
|
Expression of Human Folate Receptor Increases the Sensitivity of
CHO Cells to Alpha Toxin--
The above results suggest that alpha
toxin, like aerolysin, can bind to several different GPI-anchored
proteins. We reasoned that the sensitivity of CHO cells to the toxin
might be increased if the cells were transfected with a gene encoding a
GPI-anchored protein. We chose to use the folate receptor gene, which
is not expressed in wild type CHO cells (22). A CHO line transfected with the folate receptor gene, CHO FR+, was 3-5-fold more sensitive to
alpha toxin than the parental CHO cell line (Fig.
8). When extracts of these cells were
examined by probing blots with biotinylated alpha toxin and
streptavidin-HRP, a band was detected having the size expected for the
recombinant folate receptor, 38 kDa (Fig. 9, lane 4). Four additional
bands detected in all the cell extracts, including the PIG-L-deficient
BAG15 cells, correspond in size to the known, endogenous,
intracellular, biotin-containing carboxylases (38). Apparently these
proteins are binding the streptavidin-HRP independent of the presence
of alpha toxin. Interestingly, no alpha toxin binding bands were
detected in the CHO lec2 cells that were absent in the BAG15 cells.
Because our evidence that the wild type cells contain a GPI-anchored
alpha toxin binding protein is compelling (Figs. 1, 2, 4, and 9), this
suggests that the Western blotting procedure used here does not detect
all alpha toxin binding proteins. We have drawn a similar conclusion
with aerolysin (15).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
The folate receptor functions as a receptor
for alpha toxin but not for aerolysin. CHO and CHO FR+ cells were
incubated with alpha toxin or aerolysin as described in the text for
1 h at 37 °C. MTT at 0.5 mg/ml was added, and the cells were
incubated at 37 °C for an additional 1 h. The blue formazan
crystals were dissolved, and cell viability was determined by measuring
A540 A650.
|
|

View larger version (105K):
[in this window]
[in a new window]
|
Fig. 9.
Alpha toxin binds to the human folate
receptor in extracts of transfected CHO cells. Cell extracts were
separated on SDS-10% polyacrylamide gels (Novex) and blotted to
nitrocellulose. Blots were incubated with biotinylated alpha toxin and
developed with HRP-streptavidin. Lane 1, CHO lec2;
lane 2, CHO lec2 UH BAG15; lane 3, CHO wild type
(FR ); lane 4, CHO FR+. Novex SeeBlue molecular weight
standards (in thousands) appear at the right, and the band
corresponding to the folate receptor is identified with an
arrow.
|
|
Solubilized Folate Receptor Is Recognized by Alpha
Toxin--
Because treatment of CHO cells with PI-PLC reduces their
sensitivity to alpha toxin (Fig. 4), it was predicted that PI-PLC treatment of the CHO FR+ cells would release the folate receptor. Western blot analysis showed that this was the case and that the folate
receptor released into the supernatant by PI-PLC treatment retained the
ability to be recognized by alpha toxin (Fig.
10). This result is consistent with the
recognition by aerolysin of contactin and Thy-1 released from rat brain
homogenates by PI-PLC treatment (Fig. 6). Clearly, the structures
recognized by alpha toxin and aerolysin do not include the diglyceride
moiety of the GPI anchor, which is cleaved off by PI-PLC and remains in
the cell membrane.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 10.
The alpha toxin binding folate receptor is
released by PI-PLC. Supernatants from 2 × 107
CHO FR+ cells treated without (lane 1) and with (lane
2) 250 milliunits of PI-PLC were separated by SDS-polyacrylamide
gel electrophoresis and blotted. The blot was developed with 2 × 10 8 M alpha toxin followed by polyclonal
anti-serum and an anti-rabbit HRP conjugate. The blot was developed
with a chemiluminescent reagent (ECL, Amersham Pharmacia Biotech).
Arrows (from top to bottom) mark the
positions of 111-, 73-, 47.5-, 33.9-, and 28.5-kDa standards.
|
|
Aerolysin Does Not Bind to the GPI-anchored Folate Receptor in CHO
Cells--
The above results provide strong evidence that alpha toxin
can bind to the folate receptor when it is expressed in CHO cells. However, the results in Fig. 8 also show that expression of the folate
receptor did not increase sensitivity to aerolysin. Consistent with
this were the results of a Western blot analysis involving incubation
with native toxins followed sequentially with the corresponding anti-toxin antibody and a secondary, HRP-conjugated antibody (Fig. 11). The folate receptor was much more
strongly recognized by alpha toxin (Fig. 11A) than by
aerolysin (Fig. 11B).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 11.
Aerolysin fails to detect the folate
receptor in extracts of transfected CHO cells. Extract
corresponding to 1.5 × 105 cells was applied to each
lane of an SDS gel, and the separated proteins were electroblotted to
nitrocellulose. Blot A was developed with alpha toxin and Blot B with
aerolysin as described in Fig. 6. Lane 1, CHO lec 2;
lane 2, CHO lec2 UH Bag15; lane 3, CHO wild type
(FR ); lane 4, CHO FR+. Double arrowheads mark
the positions of 51.4-kDa (top) and 34-kDa
(bottom) standards.
|
|
GPI-deficient Cells That Are Completely Insensitive to Alpha Toxin
Retain Some Sensitivity to Aerolysin--
Further evidence that the
two toxins have different receptors is provided from data obtained
using other GPI anchor-deficient cell lines. The wild type cell line
BW5147.3 is sensitive to both toxins. A mutant of this cell line
lacking GPI-anchored proteins, BW5147.3(Thy-1
e).10, is
completely resistant to alpha toxin (Fig.
12), but retains some limited
sensitivity to aerolysin. A difference in action of the two toxins was
also seen in Fig. 5, but not in Fig. 1. The fact that all GPI
anchor-deficient cells are insensitive to alpha toxin suggests that
GPI-anchored proteins are the sole means of attachment of this toxin to
cells. The mutant cells retain some sensitivity to aerolysin because
this Aeromonas toxin contains the carbohydrate-binding small
lobe that mediates binding to membrane proteins, such as
glycophorin, that are not GPI-anchored
(39).2

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 12.
Aerolysin but not alpha toxin retains some
toxicity for GPI anchor-deficient cell lines. BW5147.3 or
BW5147.3(Thy-1 e).10 cells were incubated with alpha toxin
or aerolysin as described for nonadherent cells. The blue formazan
crystals produced from MTT were dissolved, and cell viability was
determined by measuring A540 A650.
|
|
 |
DISCUSSION |
Because cytotoxic bacterial toxins are powerful selective tools,
it is relatively easy to isolate toxin-resistant mutants, some of which
have defective receptors. CHO cells are especially useful in such
studies because they are functionally hemizygous at many loci, so that
recessive mutations can be obtained that cannot be selected in other
cell types.
This work began as an effort to use genetic methods to identify
cellular components required for the cytotoxic action of C. septicum alpha toxin. We mutagenized CHO cells by retroviral
insertion and obtained alpha toxin-resistant mutants, including the CHO lec2 UH BAG15 clone described in this communication. We intended to
then use the inserted retrovirus as a physical marker to identify the
mutated gene. However, this became unnecessary when independent work by
some of us showed that the structurally related toxin aerolysin uses a
subset of GPI-anchored cell-surface proteins as receptors, apparently
recognizing the anchor itself (15). This led us to consider that the
alpha toxin might use the same class of receptors and that the product
of the disrupted gene in the CHO lec2 UH BAG15 clone might be required
for the synthesis of GPI-anchored proteins.
The mutant cells were found to be resistant to killing by both alpha
toxin and aerolysin, consistent with the idea of a common receptor, but
also consistent with a defect in some step subsequent to binding. Alpha
toxin binding measurements using FACScan confirmed that the BAG15 cells
were completely unable to bind the toxin. What is more, treatment of
normal CHO cells with PI-PLC decreased their sensitivity, not only to
aerolysin, but also to alpha toxin, an indication that both proteins
bind to GPI-anchored receptors on the cell surface. The cells did not
become completely refractory to either toxin, probably because it is
difficult to achieve release of more than 90% of GPI-anchored proteins
from the cell surface by PI-PLC treatment (17) and because new
GPI-anchored proteins are delivered to the cell surface during the
exposure to toxin.
Several T lymphocyte cell lines that are unable to make GPI-anchored
proteins are known to be resistant to aerolysin, and this gave us a
clue to the mutation in the BAG15 clone. We were then able to show that
the cells are deficient in the second enzyme in the pathway, PIG-L.
Comparable mutants of other cell lines have been described previously
(35, 40).
Although the anchors of all GPI-anchored proteins have the same core
structure, there are species and cell type variations in the sugars and
phosphoethanolamines that modify the core (37). Our results show that
the relative affinities of aerolysin and alpha toxin for individual
proteins with these anchors differ. This was especially striking with
two proteins, Thy-1, which is bound much more strongly by aerolysin
than by alpha toxin, and the folate receptor, which is bound more
strongly by alpha toxin. Thus there must be a difference in the
structures of the two toxins that affects the specificity of their
interactions with different GPI-anchored proteins. The most obvious
difference is the presence of the small lobe in aerolysin (12). This
lobe contains a fold that is similar to the carbohydrate-binding
domains of other proteins, and we have recent evidence that it
facilitates aerolysin binding to GPI-anchored proteins as well as to
glycoproteins that are not GPI-anchored. The presence of the small lobe
in aerolysin accounts for the fact that certain GPI anchor-deficient
cells retain some sensitivity to the Aeromonas toxin
although they are completely resistant to alpha toxin. The ability of
aerolysin to act on GPI anchor-deficient cells might, for example,
involve a low affinity interaction of the small lobe with cell surface glycoproteins or glycolipids. The absence of certain glycosylations in
the CHO lec2 parent of the BAG15 mutant would then explain the complete
resistance of the BAG15 mutant to aerolysin (Fig. 1). The alpha toxin,
lacking a carbohydrate recognition region, would not have residual
affinity for GPI anchor-deficient cells, even those fully proficient in glycosylation.
The steps in GPI anchor biosynthesis are biochemically well defined.
Nevertheless, it may be useful to exploit the powerful selective
ability of alpha toxin and aerolysin to produce additional mutants
defective in GPI synthesis. It may be particularly useful to produce
such mutants in CHO cells, because the hearty nature and rapid growth
of these cells make them a convenient model system.
The strong selective action of aerolysin and alpha toxin on cells
containing GPI-anchored proteins suggests that they could be useful
reagents in genetic manipulation of cells. For example, to achieve
site-specific integration of an exogenous gene by homologous recombination, one could design targeting vectors containing flanking regions of a gene such as PIG-L that encodes an enzyme essential to GPI
anchor synthesis. Successful homologous integration would disrupt the
gene, allowing selection of the rare integrants by treatment with the
toxins. Alternatively, in mutant cells lacking an enzyme such as PIG-L,
an expression vector containing the PIG-L gene could provide a positive
selection, with transfected cells being selected by FACS or magnetic
cell sorting.
Finally, we anticipate that the recognition that two related toxins
bind differently to GPI-anchored proteins will aid attempts to
understand the structural basis for interaction of these toxins with
receptors. It will be especially useful to measure the affinities of
the two toxins for the GPI anchor and then to study the effects of
structural variations in the GPI core structure and its accessory modifications. One can anticipate that solving the structure of the
toxin complexed with a GPI anchor will be particularly informative and
can be achieved by using the known structure of aerolysin (9).
 |
ACKNOWLEDGEMENTS |
We thank Karen Fujii, Neil Hardegen, and Hui
Zhang for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grants RO1GM51419 (to V. L. S.) and AI37657 (to R. K. T.) and funds from the Natural Sciences and Engineering Research Council of
Canada (to J. T. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Oral Infection and
Immunity Branch, NIDCR, National Institutes of Health, Bldg. 30, Rm.
316, 30 Convent Dr., MSC 4350, Bethesda, MD 20892-4350. Tel.:
301-594-2865; Fax: 301-402-0396; E-mail: Leppla@nih.gov.
2
C. R. Mackenzie and J. T. Buckley, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
GPI, glycosylphosphatidylinositol;
HRP, horseradish peroxidase;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
PIG-L, N-acetylglucosaminyl-phosphatidylinositol
deacetylase-L;
PI-PLC, phosphatidylinositol-specific phospholipase C;
FR, folate receptor;
CHO, Chinese hamster ovary.
 |
REFERENCES |
| 1.
|
Stevens, D. L.,
Musher, D. M.,
Watson, D. A.,
Eddy, H.,
Hamill, R. J.,
Gyorkey, F.,
Rosen, H.,
and Mader, J.
(1990)
Rev. Infect. Dis.
12,
286-296[Medline]
[Order article via Infotrieve]
|
| 2.
|
Larson, C. M.,
Bubrick, M. P.,
Jacobs, D. M.,
and West, M. A.
(1995)
Surgery
118,
592-597[CrossRef][Medline]
[Order article via Infotrieve]; Discussion, 597-598
|
| 3.
|
Ballard, J.,
Bryant, A.,
Stevens, D.,
and Tweten, R. K.
(1992)
Infect. Immun.
60,
784-790[Abstract/Free Full Text]
|
| 4.
|
Parker, M. W.,
van der Goot, F. G.,
and Buckley, J. T.
(1996)
Mol. Microbiol.
19,
205-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Ballard, J.,
Sokolov, Y.,
Yuan, W. L.,
Kagan, B. L.,
and Tweten, R. K.
(1993)
Mol. Microbiol.
10,
627-634[Medline]
[Order article via Infotrieve]
|
| 6.
|
Howard, S. P.,
and Buckley, J. T.
(1985)
J. Bacteriol.
163,
336-340[Abstract/Free Full Text]
|
| 7.
|
Gordon, V. M.,
Benz, R.,
Fujii, K.,
Leppla, S. H.,
and Tweten, R. K.
(1997)
Infect. Immun.
65,
4130-4134[Abstract]
|
| 8.
|
Sellman, B. R.,
Kagan, B. L.,
and Tweten, R. K.
(1997)
Mol. Microbiol.
23,
551-558[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Parker, M. W.,
Buckley, J. T.,
Postma, J. P.,
Tucker, A. D.,
Leonard, K.,
Pattus, F.,
and Tsernoglou, D.
(1994)
Nature
367,
292-295[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
van der Goot, F. G.,
Lakey, J.,
Pattus, F.,
Kay, C. M.,
Sorokine, O.,
Van Dorsselaer, A.,
and Buckley, J. T.
(1992)
Biochemistry
31,
8566-8570[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Buckley, J. T.,
Wilmsen, H. U.,
Lesieur, C.,
Schulze, A.,
Pattus, F.,
Parker, M. W.,
and van der Goot, F. G.
(1995)
Biochemistry
34,
16450-16455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Rossjohn, J.,
Buckley, J. T.,
Hazes, B.,
Murzin, A. G.,
Read, R. J.,
and Parker, M. W.
(1997)
EMBO J.
16,
3426-3434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Howard, S. P.,
and Buckley, J. T.
(1982)
Biochemistry
21,
1662-1667[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Nelson, K. L.,
Raja, S. M.,
and Buckley, J. T.
(1997)
J. Biol. Chem.
272,
12170-12174[Abstract/Free Full Text]
|
| 15.
|
Diep, D. B.,
Nelson, K. L.,
Raja, S. M.,
Pleshak, E. N.,
and Buckley, J. T.
(1998)
J. Biol. Chem.
273,
2355-2360[Abstract/Free Full Text]
|
| 16.
|
Gruber, H. J.,
Wilmsen, H. U.,
Cowell, S.,
Schindler, H.,
and Buckley, J. T.
(1994)
Mol. Microbiol.
14,
1093-1101[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Low, M. G.
(1987)
Biochem. J.
244,
1-13[Medline]
[Order article via Infotrieve]
|
| 18.
|
Moehring, J. M.,
and Moehring, T. J.
(1979)
Somat. Cell Genet.
5,
453-468
|
| 19.
|
FitzGerald, D. J.,
Fryling, C. M.,
Zdanovsky, A.,
Saelinger, C. B.,
Kounnas, M.,
Winkles, J. A.,
Strickland, D.,
and Leppla, S.
(1995)
J. Cell Biol.
129,
1533-1541[Abstract/Free Full Text]
|
| 20.
|
Ballard, J.,
Crabtree, J.,
Roe, B. A.,
and Tweten, R. K.
(1995)
Infect. Immun.
63,
340-344[Abstract]
|
| 21.
|
Buckley, J. T.
(1990)
Biochem. Cell Biol.
68,
221-224[Medline]
[Order article via Infotrieve]
|
| 22.
|
Chung, K. N.,
Roberts, S.,
Kim, C. H.,
Kirassova, M.,
Trepel, J.,
and Elwood, P. C.
(1995)
Arch. Biochem. Biophys.
322,
228-234[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Deutscher, S. L.,
Nuwayhid, N.,
Stanley, P.,
Briles, E. I.,
and Hirschberg, C. B.
(1984)
Cell
39,
295-299[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Price, J.,
Turner, D.,
and Cepko, C.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
156-160[Abstract/Free Full Text]
|
| 25.
|
Cory, A. H.,
Owen, T. C.,
Barltrop, J. A.,
and Cory, J. G.
(1991)
Cancer Commun.
3,
207-212[Medline]
[Order article via Infotrieve]
|
| 26.
|
Stevens, V. L.
(1993)
J. Biol. Chem.
268,
9718-9724[Abstract/Free Full Text]
|
| 27.
|
Smith, P. K.,
Krohn, R. I.,
Hermanson, G. T.,
Mallia, A. K.,
Gartner, F. H.,
Provenzano, M. D.,
Fujimoto, E. K.,
Goeke, N. M.,
Olson, B. J.,
and Klenk, D. C.
(1985)
Anal. Biochem.
150,
76-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Bligh, E. A.,
and Dyer, W. J.
(1959)
Can. J. Biochem.
37,
911-937[Medline]
[Order article via Infotrieve]
|
| 29.
|
Stevens, V. L.,
and Zhang, H.
(1994)
J. Biol. Chem.
269,
31397-31403[Abstract/Free Full Text]
|
| 30.
|
Cowell, S.,
Aschauer, W.,
Gruber, H. J.,
Nelson, K. L.,
and Buckley, J. T.
(1997)
Mol. Microbiol.
25,
343-350[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Eiden, M. V.,
Farrell, K.,
and Wilson, C. A.
(1994)
J. Virol.
68,
626-631[Abstract/Free Full Text]
|
| 32.
|
Stanley, P.
(1983)
Somat. Cell Genet.
9,
593-608
|
| 33.
|
Adair, G. M.,
and Siciliano, M. J.
(1986)
Somat. Cell Mol. Genet.
12,
111-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Nakamura, N.,
Inoue, N.,
Watanabe, R.,
Takahashi, M.,
Takeda, J.,
Stevens, V. L.,
and Kinoshita, T.
(1997)
J. Biol. Chem.
272,
15834-15840[Abstract/Free Full Text]
|
| 35.
|
Stevens, V. L.,
Zhang, H.,
and Harreman, M.
(1996)
Biochem. J.
313,
253-258
|
| 36.
|
Sugiyama, E.,
DeGasperi, R.,
Urakaze, M.,
Chang, H. M.,
Thomas, L. J.,
Hyman, R.,
Warren, C. D.,
and Yeh, E. T.
(1991)
J. Biol. Chem.
266,
12119-12122[Abstract/Free Full Text]
|
| 37.
|
Stevens, V. L.
(1995)
Biochem. J.
310,
361-370
|
| 38.
|
Chandler, C. S.,
and Ballard, F. J.
(1986)
Biochem. J.
237,
123-130[Medline]
[Order article via Infotrieve]
|
| 39.
|
Diep, D. B.,
Nelson, K. L.,
Lawrence, T. S.,
Sellman, B. R.,
Tweten, R. K.,
and Buckley, J. T.
(1999)
Mol. Microbiol.
31,
785-794[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Mohney, R. P.,
Knez, J. J.,
Ravi, L.,
Sevlever, D.,
Rosenberry, T. L.,
Hirose, S.,
and Medof, M. E.
(1994)
J. Biol. Chem.
269,
6536-6542[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Chassin, M. Bens, J. de Barry, R. Courjaret, J. L. Bossu, F. Cluzeaud, S. Ben Mkaddem, M. Gibert, B. Poulain, M. R. Popoff, et al.
Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells
Am J Physiol Renal Physiol,
September 1, 2007;
293(3):
F927 - F937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakayama, J. Hisatsune, E. Yamasaki, Y. Nishi, A. Wada, H. Kurazono, J. Sap, K. Yahiro, J. Moss, and T. Hirayama
Clustering of Helicobacter pylori VacA in Lipid Rafts, Mediated by Its Receptor, Receptor-Like Protein Tyrosine Phosphatase {beta}, Is Required for Intoxication in AZ-521 Cells
Infect. Immun.,
December 1, 2006;
74(12):
6571 - 6580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tashima, R. Taguchi, C. Murata, H. Ashida, T. Kinoshita, and Y. Maeda
PGAP2 Is Essential for Correct Processing and Stable Expression of GPI-anchored Proteins
Mol. Biol. Cell,
March 1, 2006;
17(3):
1410 - 1420.
[Abstract]
[Full Text]
|